Diseases often start 3 to 20 years before they are detected
Claude AI Opus 5.5 - research mode Nov 2026
| Years (onset → diagnosis) | Health problem | What starts the clock | Ref |
|---|---|---|---|
| ~30–50 (inferred) | Heart attack / coronary artery disease | Fatty streaks and plaques in arteries, already present at age 15–19[1] | PDAY 1993 PDAY JAMA 1999 |
| ~20–40 (inferred) | Osteoporosis → first fragility fracture | Bone loss after peak bone mass (~age 30), speeding up at menopause[10] | Merck Manual NIAMS |
| Up to ~25 (modeled); ~4 preclinical | Colorectal cancer | Adenoma (polyp) appears; then a silent but screen-detectable cancer phase[11] | Brenner 2013 CISNET validation |
| 15–25 | Alzheimer's disease | Amyloid buildup in the brain (biomarkers)[2][12] | DIAN, Alzforum DIAN-TU protocol |
| ~15–20 (modeled) | Pancreatic cancer | First cancer-driving mutation (avg 11.7 years to non-metastatic tumor, +6.8 years to metastasis, Yachida 2010) | Yachida 2010 HHMI |
| 15–20 (5–10 with weak immunity) | Cervical cancer | Persistent HPV infection[6] | WHO |
| >10, often 20+ (modeled) | Ovarian cancer | Whole-genome doubling in tumor cells[7][13][14][15] | Gerstung 2020 Crick summary |
| ~10 (non-motor); 4–6 (neuron loss) | Parkinson's disease | Smell loss, sleep disorder, constipation; dopamine-neuron loss[16][17] | Gaenslen 2011 Prodromal PD review |
| Up to 15–20 (missed chances) | COPD | Lower-respiratory symptoms seen by doctors[18][19] | Jones 2014 |
| 4–7 to 9–12 | Type 2 diabetes | High blood sugar (dated back from retinopathy at diagnosis)[20] | Harris 1992 Porta 2014 |
| 5–12 (lead time) | Prostate cancer | PSA-detectable cancer vs. clinical diagnosis[8][9] | Draisma 2003 ERSPC lead time |
| ~3–10 | Celiac disease (adults) | First symptoms | Norström 2011 Poland 2022 |
| ~7 (range 1.5–11) | Endometriosis | First symptoms (pelvic pain, painful periods)[21][22] | Scoping review 2024 Netherlands 2025 |
| ~7 | Axial spondyloarthritis (ankylosing spondylitis) | First symptoms (inflammatory back pain)[23] | Zhao 2021 meta-analysis |
| ~6–9 | Bipolar disorder | First mood episode or symptoms[24][25] | Dagani 2017 Lublóy 2020 |
| ~5 (up to 18) | Rheumatoid arthritis | Autoantibodies (anti-CCP, RF) in blood[26][27] | Anti-CCP timing study ACPA review |
| 4.7 (median 0.75)[28] | Rare diseases (overall) | First symptoms | EURORDIS 2024 |
| ~3.3 (up to 9.4)[29] | Lupus (SLE) | Autoantibodies in stored blood samples | Arbuckle 2003 |
| 2–7 (preclinical)[30][31][32] | Breast cancer | Tumor detectable on mammogram | Ryser 2022 Weedon-Fekjær 2005 |
| ~3.5 (weeks to 18)[33] | Type 1 diabetes (children) | Multiple islet autoantibodies | TEDDY/JAMA 2013 DIPP 2012 |
| ≥5 (prodrome) | Multiple sclerosis | Rising health-care use before first demyelinating event[34] | Wijnands 2017 |
| ~1–3 (diagnosis mean ~5 years old) | Autism | First signs noticed by parents (~1–2 years old)[35][36] | van 't Hof 2021 First-concern study |
| Years–decades (not well quantified) | Lung cancer | Smoking-signature mutations in tumors of long-term ex-smokers[37] | TRACERx 2017 |
Sources:
- PDAY 1993
- PDAY JAMA 1999
- Merck Manual osteoporosis
- NIAMS osteoporosis
- IOF World Osteoporosis Day 2024
- Brenner 2013
- CISNET validation
- DIAN, Alzforum
- DIAN-TU protocol
- Yachida 2010
- HHMI
- WHO cervical cancer
- Gerstung 2020
- Crick summary
- Gaenslen 2011
- Prodromal PD review
- Jones 2014
- Harris 1992
- Porta 2014
- Draisma 2003
- ERSPC lead time
- Norström 2011
- Poland 2022
- Scoping review 2024
- Netherlands 2025
- Zhao 2021 meta-analysis
- Dagani 2017
- Lublóy 2020
- Anti-CCP timing study
- ACPA review
- EURORDIS 2024
- Arbuckle 2003
- Ryser 2022
- Weedon-Fekjær 2005
- TEDDY/JAMA 2013
- DIPP 2012
- Wijnands 2017
- van 't Hof 2021
- First-concern study
- TRACERx 2017
Sources
- Natural history of aortic and coronary atherosclerotic lesions in youth. Findings from the PDAY Study. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group - PubMed
- Aβ, Then Metabolism, Then Atrophy: In Familial AD, Cascade is Definitive
- Prevention Strategy For Alzheimer’s Disease Now On The Horizon
- Biomarkers for Inherited Alzheimer's Disease Emerge Decades Before Symptoms Manifest
- Revising the Timeline for Deadly Pancreatic Cancer
- Cervical cancer
- The evolutionary history of 2,658 cancers
- Lead Times and Overdetection Due to Prostate-Specific Antigen Screening: Estimates from the European Randomized Study of Screening for Prostate Cancer
- Lead-time in the European Randomised Study of Screening for Prostate Cancer - European Journal of Cancer
- Osteoporosis - Rheumatology and Orthopedics - Merck Manual Professional Edition
- Validation of Models Used to Inform Colorectal Cancer Screening Guidelines: Accuracy and Implications
- Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia: A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation
- The evolutionary history of 2,658 cancers
- The evolutionary history of cancer
- The evolutionary history of 2,658 cancers
- The premotor phase of Parkinson's disease - ScienceDirect
- The patients' perception of prodromal symptoms before the initial diagnosis of Parkinson's disease<link href='#fn1'></link> - Gaenslen - 2011 - Movement Disorders - Wiley Online Library
- Towards earlier diagnosis of COPD - The Lancet Respiratory Medicine
- Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort - PubMed
- Onset of NIDDM occurs at least 4-7 yr before clinical diagnosis - PubMed
- Diagnostic delay in endometriosis: is there any progress? - Reproductive BioMedicine Online
- Full article: Understanding diagnostic delay for endometriosis: A scoping review using the social-ecological framework
- Systematic review and meta-analysis of diagnostic delay in axial spondyloarthritis - The University of Liverpool Repository
- Exploring factors of diagnostic delay for patients with bipolar disorder: a population-based cohort study - PMC
- Meta-analysis of the Interval between the Onset and Management of Bipolar Disorder - Jessica Dagani, Giulia Signorini, Olav Nielssen, Moira Bani, Adriana Pastore, Giovanni de Girolamo, Matthew Large, 2017
- The Duration of Pre-Clinical Rheumatoid Arthritis-Related Autoantibody Positivity Increases in Subjects with Older Age at Time of Disease Diagnosis - PMC
- The role of anti-citrullinated protein antibodies (ACPA) in the pathogenesis of rheumatoid arthritis - PMC
- Time to diagnosis and determinants of diagnostic delays of people living with a rare disease: results of a Rare Barometer retrospective patient survey
- Development of autoantibodies before the clinical onset of systemic lupus erythematosus - PubMed
- Estimation of Breast Cancer Overdiagnosis in a U.S. Breast Screening Cohort
- Inference of Onset Age of Preclinical State and Sojourn Time for Breast Cancer - PMC
- Estimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results - PubMed
- Islet autoantibody seroconversion precedes type 1 diabetes
- Google Scholar
- Age at autism spectrum disorder diagnosis: A systematic review and meta-analysis from 2012 to 2019 - Maarten van ’t Hof, Chanel Tisseur, Ina van Berckelear-Onnes, Annemyn van Nieuwenhuyzen, Amy M Daniels, Mathijs Deen, Hans W Hoek, Wietske A Ester, 2021
- Autistic clinical profiles, age at first concern, and diagnosis among children with autism spectrum disorder - PMC
- Tracking the Evolution of Non–Small-Cell Lung Cancer
- (PDF) Estimating the Delay Between Onset and Diagnosis of Type 2 Diabetes From the Time Course of Retinopathy Prevalence
- (PDF) Weedon-Fekjaer H, LIndqvist BH, Vatten LJ, Aalen O, Tretli SEstimating mean sojourn time and screening test sensitivity in breast cancer mammography screening: new results. J Med Screen 12: 172-178
- ERIC - EJ1294525 - Age at Autism Spectrum Disorder Diagnosis: A Systematic Review and Meta-Analysis from 2012 to 2019, Autism: The International Journal of Research and Practice, 2021-May